Open original FDA record ↗Recall record
- FDA identifier
- Z-0306-2017
- Company in FDA record
- Hospira Inc.
- FDA record creation date
- Oct 24, 2016
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Symbiq Infusers have the potential to experience a white screen during titration of a Keep Vein Open (KVO) delivery. This can allow the clinician to select the "NEXT" button prior to completion of the programming. If this error occurs, a delay in therapy could occur and potentially result in significant injury.
Source facts
- Action
- Hospira sent an Urgent Device Field Correction notice dated February 4, 2013, to all affected customers. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to follow the steps provided in the letter while Hospira is developing a software change. Customers were asked to complete the attached reply form and return it via fax to the number on the form. Customers with questions were instructed to contact Stericycle at 1-888-201-9332. For questions regarding this recall call 224-212-4892.
- Initiated
- 2013-02-04
- Root cause
- Software design
- Terminated
- 2016-12-15
- Distribution
- Worldwide Distribution - USA (nationwide) and Canada
- Recall number
- Z-0306-2017
- Recall status
- Terminated
- CDRH record ID
- 115186
- FDA record created
- 2016-10-24
- Recall event number
- 63994